Validity and Reliability of the Turkish Version of the Post-Liver Transplant Quality of Life Questionnaire

Hacettepe University

Status: Active, not recruiting

Conditions: Quality of Life; Liver Transplant Disorder

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT06577480

SBA 24/665

Details and patient eligibility

About

Liver transplantation is a crucial treatment for life-threatening liver diseases, including acute liver failure, end-stage chronic liver disease, primary liver cancers, and congenital metabolic disorders. Quality of life in liver transplant patients is vital. The World Health Organization defines quality of life as an individual's perception of their position in life within the context of culture, values, goals, and expectations. Liver transplantation improves quality of life. Recipients should be closely monitored and supported psychologically, with the effectiveness of the intervention in improving quality of life well-documented. Saab et al. developed the post-Liver Transplantation Quality of Life (pLTQ) questionnaire, which includes eight sub-dimensions across 32 items. To our knowledge, no Turkish-specific QoL tool for liver transplant patients currently exists. This study aims to validate and assess the reliability of the Turkish version of the pLTQ questionnaire.

Enrollment: 80 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Being 18 years of age or older,
• Having received post-liver transplant treatment at Hacettepe University Adult Hospital General Surgery Units and being referred to Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit after routine clinical and laboratory examinations, if deemed appropriate for the study,
• Being willing to participate in the study.

Exclusion criteria

• Having undergone combined liver-kidney transplantation and multiple organ transplantation,
• Having uncontrolled cardiovascular and neurological problems,
• Having a cognitive problem that will prevent understanding the questionnaires,
• Not being willing to participate in the study.

Trial design

80 participants in 1 patient group

Liver transplant recipients

Treatment:

Other: No intervention